Strategy 9.5
Just refining my idea on the trial. With the breast cancer cardio protect anti cancer / FTO / CDx 3 in 1.
1. Trial must be structured from the outset with use of CDx.
2. Can run BC (inc mBC) Cardio protect and FTO trial in one.
3. Use genetic data for Pre marketing approval (PMA) for post approval 501(k).
4. Trial to be a satisfied randomised trial design, MAMS or FOCUS4 design to provide proof of concept with Dox + Zan.
5. Majority of sites in Australia R&D grant and less expensive.
6. Also given low patient population for mBC recruitment challenges so overseas trial EUR or US and apply overseas advance finding ruling to claim R&D for overseas costs.
7. Then payout COH early exit payment - due to transaction occurring before 8 July 2027 P3 first patient dosed deadline.
8. Retire!….
p.s. still having a think about AML and happy to be corrected by anyone on here : )
Strategy 9.5Just refining my idea on the trial. With the breast...
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.45 |
Change
-0.005(0.34%) |
Mkt cap ! $242.5M | |||
| Open | High | Low | Value | Volume |
| $1.46 | $1.50 | $1.43 | $62.91K | 43.17K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 5700 | $1.43 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.45 | 591 | 1 |
View Market Depth
| Last trade - 16.10pm 24/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.46 |
Change
-0.005 ( 0.23 %) |
||||
| Open | High | Low | Volume | ||
| $1.44 | $1.49 | $1.43 | 9034 | ||
| Last updated 13.08pm 24/05/2024 ? | |||||
| RAC (ASX) Chart |